Menopause

The Lancet

Volumn 371, Issue 9614, 2008, Pages 760-770

  Nelson, Heidi D ^a,b,c  

^a Oregon Evidence based Practice Center   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c EARLE A CHILES RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BIOCHANIN A; CIMICIFUGA RACEMOSA EXTRACT; CLONIDINE; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; DAIDZEIN; ESTRADIOL; ESTROGEN; FORMONONETIN; GABAPENTIN; GENISTEIN; GESTAGEN; HYPERICUM PERFORATUM EXTRACT; ISOFLAVONE; MEGESTROL; METHYLDOPA; MOCLOBEMIDE; PAROXETINE; PHYTOESTROGEN; PLACEBO; PROGESTERONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TAMOXIFEN; TESTOSTERONE; TIBOLONE; VENLAFAXINE; VERALIPRIDE;

ACUPUNCTURE; BREAST CANCER; BREAST TENDERNESS; CARDIOVASCULAR DISEASE; CHOLECYSTITIS; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEPRESSION; DIAGNOSTIC PROCEDURE; DIZZINESS; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; EXERCISE; FEMALE GENITAL SYSTEM; HEADACHE; HOT FLUSH; HUMAN; LIVER DISEASE; MENOPAUSAL SYNDROME; MENSTRUAL CYCLE; META ANALYSIS; NAUSEA AND VOMITING; PAIN; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RASH; REVIEW; SEIZURE; SIDE EFFECT; SYSTEMATIC REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; UTERUS BLEEDING; VASOMOTOR DISORDER; VENOUS THROMBOEMBOLISM; WEIGHT CHANGE; WEIGHT GAIN;

EID: 39649101096     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60346-3     Document Type: Review

References (126)

1. Nelson H., Haney E., Humphrey L., et al. Management of menopause-related symptoms. Evidence Report/Technology Assessment 120 (2005), Agency for Healthcare Research and Quality, Rockville, MD
2. Dudley E., Hopper J., Taffe J., Guthrie J., Burger H., and Dennerstein L. Using longitudinal data to define the perimenopause by menstrual cycle characteristics. Climacteric 1 (1998) 18-25
3. Taffe J., and Dennerstein L. Menstrual patterns leading to the final menstrual period. Menopause 9 (2002) 32-40
4. Soules M., Sherman S., Parrott E., et al. Executive Summary: stages of reproductive aging workshop (STRAW), Park City, Utah, July 2001. Menopause 8 (2001) 402-407
5. Johnston J., Colvin A., Johnson B., et al. Comparison of SWAN and WISE Menopausal Status Classification Algorithms. J Women Health 15 (2006) 1184-1194
6. Harlow S., Cain K., Crawford S., et al. Evaluation of four proposed bleeding criteria for the onset of late menopausal transition. J Clin Endocrinol Metab 91 (2006) 3432-3438
7. Randolph Jr. J., Crawford S., Dennerstein L., et al. The value of follicle-stimulating hormone concentration and clinical findings as markers of the late menopausal transition. J Clin Endocrinol Metab 91 (2006) 3034-3040
8. Mansfield P., Carey M., Anderson A., Barsom S., and Koch P. Staging the menopausal transition: data from the TREMIN Research Program on Women's Health. Womens Health Issues 14 (2004) 220-226
9. North American Menopause Society. Menopause Guidebook, 6th edn. http://www.menopause.org/MGI.pdf (accessed April 6, 2007).
10. Gold E., Bromberger J., Crawford S., et al. Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol 153 (2001) 865-874
11. Melby MK, Lock M, Kaufert P. Culture and symptom reporting at menopause. Hum Reprod Update; 11: 495-512.
12. North American Menopause Society. http://www.menopause.org (accessed Dec 13, 2004).
13. Casper R., and Yen S. Neuroendocrinology of menopausal flushes: a hypothesis of flush mechanism. Clin Endocrinol 22 (1985) 293-312 (Oxf)
14. Freedman R., Norton D., Woodward S., and Cornelissen G. Core body temperature and circadian rhythm of hot flashes in menopausal women. J Clin Endocrinol Metab 80 (1995) 2354-2358
15. Freedman R., and Krell W. Reduced thermoregulatory null zone in postmenopausal women with hot flashes. Am J Obstet Gynecol 181 (1999) 66-70
16. Avis N., Brockwell S., and Colvin A. A universal menopausal syndrome?. Am J Med 118 suppl 2 (2005) 37-46
17. Greene J. A factor analytic study of climacteric symptoms. J Psychosom Res 20 (1976) 425-430
18. National Institutes of Health. Assessing and improving measures of hot flashes: summary of an NIH workshop (Jan 20, 2004), Rose Li and Associates, Bethesda, MD
19. Hilditch J., Lewis J., Peter A., et al. A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas 24 (1996) 161-175
20. Brown W., Mishra G., and Dobson A. Changes in physical symptoms during the menopause transition. Int J Behav Med 9 (2002) 53-67
21. Hardy R., and Kuh D. Change in psychological and vasomotor symptom reporting during the menopause. Soc Sci Med 55 (2002) 1975-1988
22. Dennerstein L., Dudley E., Hopper J., Guthrie J., and Burger H. A prospective population-based study of menopausal symptoms. Obstet Gynecol 96 (2000) 351-358
23. Koster A., Eplov L., and Garde K. Anticipations and experiences of menopause in a Danish female general population cohort born in 1936. Arch Womens Ment Health 5 (2002) 9-13
24. Kaufert P., Gilbert P., and Tate R. The Manitoba Project: a re-examination of the link between menopause and depression. Maturitas 14 (1992) 143-155
25. Avis N., Brambilla D., McKinlay S., and Vass K. A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women's Health Study. Ann Epidemiol 4 (1994) 214-220
26. McKinlay S., and McKinlay J. The impact of menopause and social factors on health. In: Hammond C., Haseltine F., and Schiff I. (Eds). Menopause: evaluation, treatment, and health concerns (1989), Alan R Liss, New York 137-161
27. Mitchell E., and Woods N. Symptom experiences of midlife women: observations from the Seattle Midlife Women's Health Study. Maturitas 25 (1996) 1-10
28. Woods N., and Mitchell E. Pathways to depressed mood for midlife women: observations from the Seattle Midlife Women's Health Study. Res Nurs Health 20 (1997) 119-129
29. Glazer G., Zeller R., Delumba L., et al. The Ohio Midlife Women's Study. Health Care Women Int 23 (2002) 612-630
30. Busch C., Zonderman A., and Costa P. Menopausal transition and psychological distress in a nationally representative sample: is menopause associated with psychological distress?. J Aging Health 6 (1994) 209-228
31. Hallstrom T., and Samuelsson S. Mental health in the climacteric. The longitudinal study of women in Gothenburg. Acta Obstet Gynecol Scand Suppl 130 (1985) 13-18
32. Mishra G., Brown W., and Dobson A. Physical and mental health: changes during menopause transition. Qual Life Res 12 (2003) 405-412
33. Dennerstein L., Lehert P., Burger H., and Dudley E. Mood and the menopausal transition. J Nerv Ment Dis 187 (1999) 685-691
34. Dennerstein L., Lehert P., Dudley E., and Guthrie J. Factors contributing to positive mood during the menopausal transition. J Nerv Ment Dis 189 (2001) 84-89
35. Freeman E., Sammel M., Lin H., and Nelson D. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 63 (2006) 375-382
36. Bromberger J., Matthews K., Brockwell S., et al. Depressive symptoms during the menopausal transition: The Study of Women's Health Across the Nation (SWAN). J Affect Disord (2007) 10.1016/j.jad.2007.01.034
37. Maartens L., Knottnerus J., and Pop V. Menopausal transition and increased depressive symptomatology: a community based prospective study. Maturitas 42 (2002) 195-200
38. Vesco K., Haney E., Humphrey L., Fu R., and Nelson H. Influences of menopause on mood: a systematic review of cohort studies. Climacteric 10 (2007) 448-465
39. Sherburn M., Guthrie J., Dudley E., O'Connell H., and Dennerstein L. Is incontinence associated with menopause?. Obstet Gynecol 98 (2001) 628-633
40. Dennerstein L., Dudley E., and Burger H. Are changes in sexual functioning during midlife due to aging or menopause?. Fertil Steril 76 (2001) 456-460
41. Dennerstein L., Randolph J., Taffe J., Dudley E., and Burger H. Hormones, mood, sexuality, and the menopausal transition. Fertil Steril 77 suppl 4 (2002) S42-S48
42. Dennerstein L., Lehert P., Burger H., and Guthrie J. Sexuality. Am J Med 118 suppl 2 (2005) 59-63
43. Boulet M., Oddens B., Lehert P., Vemer H., and Visser A. Climacteric and menopause in seven South-east Asian countries. Maturitas 19 (1994) 157-176
44. Avis N., Stellato R., Crawford S., et al. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med 52 (2001) 345-356
45. Gold E., Sternfeld B., Kelsey J., et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol 152 (2000) 463-473
46. Kravitz H., Ganz P., Bromberger J., Powell L., Sutton-Tyrrell K., and Meyer P. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause 10 (2003) 19-28
47. Avis N., Ory M., Matthews K., Schocken M., Bromberger J., and Colvin A. Health-related quality of life in a multiethnic sample of middle-aged women: Study of Women's Health Across the Nation (SWAN). Med Care 41 (2003) 1262-1276
48. Haines C., Xing S.-M., Park K.-H., Holinka C., and Ausmanas M. Prevalence of menopausal symptoms in different ethnic groups of Asian women and responsiveness to therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study. Maturitas 52 (2005) 264-276
49. Ghali W., Freund K., Boss R., Ryan C., and Moskowitz M. Menopausal hormone therapy: physician awareness of patient attitudes. Am J Med 103 (1997) 3
50. Nelson H. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review. JAMA 291 (2004) 1610-1620
51. MacLennan A., Broadbent J., Lester S., and Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev (2004) CD002978.
52. Nelson H., Vesco K., Haney E., et al. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 295 (2006) 2057-2071
53. US Preventive Services Task Force. Hormone replacement therapy for the prevention of chronic conditions in postmenopausal women. http://www.ahrq.gov/clinic/uspstf/uspspmho.htm (accessed April 6, 2007).
54. Grady D., and Sawaya G. Discontinuation of postmenopausal hormone therapy. Am J Med 118 suppl 2 (2005) 163-165
55. MacLennan A., Lester S., and Moore V. Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review. Climacteric 4 (2001) 58-74
56. Nelson H. Postmenopausal estrogen for treatment of hot flashes: clinical applications. JAMA 291 (2004) 1621-1625
57. Chlebowski R., Hendrix S., Langer R., et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 289 (2003) 3243-3253
58. Rossouw J., Anderson G., Prentice R., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
59. The Women's Health Initiative Steering Committee. effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative Randomized Controlled Trial. JAMA 291 (2004) 1701-1712
60. Rossouw J., Prentice R., Manson J., et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297 (2007) 1465-1477
61. Wren B., Champion S., Willetts K., Manga R., and Eden J. Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for postmenopausal women. Menopause 10 (2003) 13-18
62. Leonetti H., Longo S., and Anasti J. Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss. Obstet Gynecol 94 (1999) 225-228
63. de Wit H., Schmitt L., Purdy R., and Hauger R. Effects of acute progesterone administration in healthy postmenopausal women and normally-cycling women. Psychoneuroendocrinology 26 (2001) 697-710
64. Morrison J., Martin D., Blair R., et al. The use of medroxyprogesterone acetate for relief of climacteric symptoms. Am J Obstet Gynecol 138 (1980) 99-104
65. Schiff I., Tulchinsky D., Cramer D., and Ryan K. Oral medroxyprogesterone in the treatment of postmenopausal symptoms. JAMA 244 (1980) 1443-1445
66. Loprinzi C., Michalak J., Quella S., et al. Megestrol acetate for the prevention of hot flashes. N Engl J Med 331 (1994) 347-352
67. Hickok L., Toomey C., and Speroff L. A comparison of esterified estrogens with and without methyltestosterone: effects on endometrial histology and serum lipoproteins in postmenopausal women. Obstet Gynecol 82 (1993) 919-924
68. Meeuwsen I., Samson M., Duursma S., and Verhaar H. The influence of tibolone on quality of life in postmenopausal women. Maturitas 41 (2002) 35-43
69. Landgren M., Helmond F., and Engelen S. Tibolone relieves climacteric symptoms in highly symptomatic women with at least seven hot flushes and sweats per day. Maturitas 50 (2005) 222-230
70. Baksu A., Ayas B., Citak S., Kalan A., Baksu B., and Goker N. Efficacy of tibolone and transdermal estrogen therapy on psychological symptoms in women following surgical menopause. Int J Gynaecol Obstet 91 (2005) 58-62
71. Sloan J., Loprinzi C., Novotny P., Barton D., LaVasseur B., and Windschitl H. Methodological lessons learned from hot flash studies. J Clin Oncol 19 (2001) 4280-4290
72. Guttuso Jr. T., Kurlan R., McDermott M., and Kieburtz K. Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 101 (2003) 337-345
73. Pandya K., Morrow G., Roscoe J., et al. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet 366 (2005) 818-824
74. Reddy S., Warner H., Guttuso Jr. T., et al. Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial. Obstet Gynecol 108 (2006) 41-48
75. Stearns V., Beebe K., Iyengar M., and Dube E. Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. JAMA 289 (2003) 2827-2834
76. Stearns V., Slack R., Greep N., et al. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. J Clin Oncol 23 (2005) 6919-6930
77. Gordon P., Kerwin J., Boesen K., and Senf J. Sertraline to treat hot flashes: a randomized controlled, double-blind, crossover trial in a general population. Menopause 13 (2006) 568-575
78. Kimmick G., Lovato J., McQuellon R., Robinson E., and Muss H. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hotflashes in women with early stage breast cancer taking tamoxifen. Breast J 12 (2006) 114-122
79. Loprinzi C., Kugler J., Sloan J., et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 356 (2000) 2059-2063
80. Carpenter J., Storniolo A., Johns S., et al. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer. Oncologist 12 (2007) 124-135
81. Bergmans M., Merkus J., Corbey R., Schellekens L., and Ubachs J. Effect of Bellergal Retard on climacteric complaints: a double-blind, placebo-controlled study. Maturitas 9 (1987) 227-234
82. Grady D., Cohen B., Tice J., Kristof M., Olyaie A., and Sawaya G. Ineffectiveness of sertraline for treatment of menopausal hot flushes. Obstet Gynecol 109 (2007) 823-830
83. Nedrow A., Miller J., Walker M., Nygren P., Huffman L., and Nelson H. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med 166 (2006) 1453-1465
84. Lewis J., Nickell L., Thompson L., Szalai J., Kiss A., and Hilditch J. A randomized controlled trial of the effect of dietary soy and flaxseed muffins on quality of life and hot flashes during menopause. Menopause 13 (2006) 631-642
85. Hidalgo L., Chedraui P., Morocho N., Ross S., and San Miguel G. The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double-blind, placebo-controlled study. Gynecol Endocrinol 21 (2005) 257-264
86. Heyerick A., Vervarcke S., Depypere H., Bracke M., and De Keukeleire D. A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas 54 (2006) 164-175
87. Dodin S., Lemay A., Jacques H., Legare F., Forest J., and Masse B. The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial. J Clin Endocrinol Metab 90 (2005) 1390-1397
88. Carranza-Lira S., Barahona O., Ramos D., et al. Changes in symptoms, lipid and hormone levels after the administration of a cream with phytoestrogens in the climacteric-preliminary report. Int J Fertil Womens Med 46 (2001) 296-299
89. Komesaroff P., Black C., Cable V., and Sudhir K. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women. Climacteric 4 (2001) 144-150
90. Osmers R., Friede M., Liske E., Schnitker J., Freudenstein J., and Henneicke-von Zepelin H.-H. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol 105 (2005) 1074-1083
91. Jacobson J., Troxel A., Evans J., et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 19 (2001) 2739-2745
92. Munoz G.H., and Pluchino S. Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer. Maturitas 44 suppl 1 (2003) S59-S65
93. Wuttke W., Seidlova-Wuttke D., and Gorkow C. The Cimicifuga preparation BNO 1055 vs conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 44 suppl 1 (2003) S67-S77
94. Newton K., Reed S., LaCroix A., Grothaus L., Ehrlich K., and Guiltinan J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo. Ann Intern Med 145 (2006) 869-879
95. Frei-Kleiner S., Schaffner W., Rahlfs V., Bodmer C., and Birkhauser M. Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial. Maturitas 51 (2005) 397-404
96. Pockaj B., Gallagher J., Loprinzi C., et al. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. J Clin Oncol 24 (2006) 2836-2841
97. Russo R., and Corosu R. The clinical use of a preparation based on phyto-oestrogens in the treatment of menopausal disorders. Acta Biomed Ateneo Parmense 74 (2003) 137-143
98. Uebelhack R., Blohmer J.-U., Graubaum H.-J., Busch R., Gruenwald J., and Wernecke K.-D. Black cohosh and St. John's wort for climacteric complaints: a randomized trial. Obstet Gynecol 107 (2006) 247-255
99. Verhoeven M., van der Mooren M., van de Weijer P., et al. Effect of a combination of isoflavones and Actaea racemosa Linnaeus on climacteric symptoms in healthy symptomatic perimenopausal women: a 12-week randomized, placebo-controlled, double-blind study. Menopause 12 (2005) 412-420
100. Chenoy R., Hussain S., Tayob Y., O'Brien P., Moss M., and Morse P. Effect of oral gamolenic acid from evening primrose oil on menopausal flushing. BMJ 308 (1994) 501-503
101. Rachev E., Nalbansky B., Kolarov G., and Agrosi M. Efficacy and safety of phospholipid liposomes in the treatment of neuropsychological disorders associated with the menopause: a double-blind, randomised, placebo-controlled study. Curr Med Res Opin 17 (2001) 105-110
102. Winther K., Rein E., and Hedman C. Femal, a herbal remedy made from pollen extracts, reduces hot flushes and improves quality of life in menopausal women: a randomized, placebo-controlled, parallel study. Climacteric 8 (2005) 162-170
103. Barnhart K., Freeman E., Grisso J., et al. The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol Metab 84 (1999) 3896-3902
104. Hudson T., Standish L., Breed C., et al. Clinical and endocrinological effects of a menopausal botanical formula. J Med Issue 7 (1998) 73-77
105. Cagnacci A., Arangino S., Renzi A., Zanni A., Malmusi S., and Volpe A. Kava-Kava administration reduces anxiety in perimenopausal women. Maturitas 44 (2003) 103-109
106. Makkonen M., Simpanen A., Saarikoski S., et al. Endocrine and metabolic effects of guar gum in menopausal women. Gynecol Endocrinology 7 (1993) 135-141
107. Barton D., Loprinzi C., Quella S., et al. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol 16 (1998) 495-500
108. Cleary C., and Fox J. Menopausal symptoms: an osteopathic investigation. Complement Ther Med 2 (1994) 181-186
109. Williamson J., White A., Hart A., and Ernst E. Randomised controlled trial of reflexology for menopausal symptoms. BJOG 109 (2002) 1050-1055
110. Carpenter J., Johnson D., Wagner L., and Andrykowski M. Hot flashes and related outcomes in breast cancer survivors and matched comparison women. Oncol Nurs Forum Online 29 (2002) E16-E25
111. Aiello E., Yasui Y., Tworoger S., et al. Effect of a yearlong, moderate-intensity exercise intervention on the occurrence and severity of menopause symptoms in postmenopausal women. Menopause 11 (2004) 382-388
112. Huang M., Nir Y., Chen B., Schnyer R., and Manber R. A randomized controlled pilot study of acupuncture for postmenopausal hot flashes: effect on nocturnal hot flashes and sleep quality. Fertil Steril 86 (2006) 700-710
113. Krebs E., Ensrud K., MacDonald R., and Wilt T. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol 104 (2004) 824-836
114. Balk E., Chung M., Chew P., et al. Effects of soy on health outcomes. Summary, Evidence Report/Technology Assessment 126 (2005), AHRQ, Rockville, MD
115. Cassidy A., Albertazzi P., Lise Nielsen I., et al. Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women. Proc Nutr Soc 65 (2006) 76-92
116. Atkinson C., Warren R., Sala E., et al. Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial. Breast Cancer Res 6 (2004) R170-R179
117. Baber R., Templeman C., Morton T., Kelly G., and West L. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 2 (1999) 85-92
118. Jeri A. The use of an isoflavone supplement to relieve hot flashes. Female Patient 27 (2002) 35-37
119. Knight D., Howes J., and Eden J. The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric 2 (1999) 79-84
120. Tice J., Ettinger B., Ensrud K., Wallace R., Blackwell T., and Cummings S. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) study: a randomized controlled trial. JAMA 290 (2003) 207-214
121. van de Weijer P., and Barentsen R. Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas 42 (2002) 187-193
122. Whiting P., Clouston A., and Kerlin P. Black cohosh and other herbal remedies associated with acute hepatitis. Med J Australia 177 (2002) 432-435
123. Nelson H., Nygren P., Freeman M., and Benjamin K. Drug Class Review on Estrogens. http://www.ohsu.edu/drugeffectiveness/reports/documents/Estrogens%20Final%20Report%20u2.pdf (accessed April 6, 2007).
124. National Institutes of Health. National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms. Ann Intern Med 142 (2005) 1003-1013
125. Stephenson J. FDA orders estrogen safety warnings: agency offers guidance for HRT use. JAMA 289 (2003) 537-538
126. North American Menopause Society. Recommendations for estrogen and progestogen use in peri-and postmenopausal women: October 2004 position statement of The North American Menopause Society. Menopause 11 (2004) 589-600